Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 1 (4), 327-48

Retinoids in the Treatment of Skin Aging: An Overview of Clinical Efficacy and Safety

Affiliations
Review

Retinoids in the Treatment of Skin Aging: An Overview of Clinical Efficacy and Safety

Siddharth Mukherjee et al. Clin Interv Aging.

Abstract

Aging of skin is an intricate biological process consisting of two types. While intrinsic or chronological aging is an inevitable process, photoaging involves the premature aging of skin occurring due to cumulative exposure to ultraviolet radiation. Chronological and photoaging both have clinically differentiable manifestations. Various natural and synthetic retinoids have been explored for the treatment of aging and many of them have shown histological and clinical improvement, but most of the studies have been carried out in patients presenting with photoaged skin. Amongst the retinoids, tretinoin possibly is the most potent and certainly the most widely investigated retinoid for photoaging therapy. Although retinoids show promise in the treatment of skin aging, irritant reactions such as burning, scaling or dermatitis associated with retinoid therapy limit their acceptance by patients. This problem is more prominent with tretinoin and tazarotene whereas other retinoids mainly represented by retinaldehyde and retinol are considerably less irritating. In order to minimize these side effects, various novel drug delivery systems have been developed. In particular, nanoparticles have shown a good potential in improving the stability, tolerability and efficacy ofretinoids like tretinoin and retinol. However, more elaborate clinical studies are required to confirm their advantage in the delivery of topical retinoids.

Figures

Figure 1
Figure 1
Chemical structures of retinoids.
Figure 2
Figure 2
N-formyl aspartame derivative of retinol.

Similar articles

See all similar articles

Cited by 44 PubMed Central articles

See all "Cited by" articles

References

    1. Abdulmajed K, Heard C. Topical delivery of retinyl-ascorbate co-drug 1. Synthesis, penetration, into and permeation across human skin. Int J Pharm. 2004;280:113–24. - PubMed
    1. Alirezai M, Dupuy R, Amblard P, et al. Clinical evaluation of topical isotretinoin in the treatment of actinic keratoses. J Am Acad Dermatol. 1994;30:447–51. - PubMed
    1. Antille C, Tran C, Sorg O, et al. Penetration and metabolism of topical retinoids in ex-vivo organ-cultured full-thickness human skin explants. Skin Pharmacol Physiol. 2004;17:124–8. - PubMed
    1. Armstrong RB, Lesiewicz J, Harvey G, et al. Clinical panel assessment of photodamaged skin treated with isotretinoin using photographs. Arch Dermatol. 1992;128:352–6. - PubMed
    1. Aslam MN, Fligiel H, Lateef H, et al. PADMA 28: A multi-component herbal preparation with retinoid like dermal activity but without epidermal effects. J Invest Dermatol. 2005;124:524–9. - PubMed

MeSH terms

Feedback